Academy Capital Management Inc. TX Has $6.84 Million Position in Core Laboratories N.V. (CLB)

Academy Capital Management Inc. TX cut its stake in shares of Core Laboratories N.V. (NYSE:CLB) by 0.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,579 shares of the oil and gas company’s stock after selling 612 shares during the period. Core Laboratories N.V. comprises about 1.9% of Academy Capital Management Inc. TX’s investment portfolio, making the stock its 22nd largest position. Academy Capital Management Inc. TX owned 0.15% of Core Laboratories N.V. worth $6,843,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the stock. Clearbridge Investments LLC raised its stake in Core Laboratories N.V. by 3.8% in the first quarter. Clearbridge Investments LLC now owns 5,219,879 shares of the oil and gas company’s stock valued at $603,000,000 after buying an additional 190,186 shares during the last quarter. WCM Investment Management CA raised its stake in Core Laboratories N.V. by 4.6% in the first quarter. WCM Investment Management CA now owns 4,130,102 shares of the oil and gas company’s stock valued at $477,109,000 after buying an additional 181,025 shares during the last quarter. Vanguard Group Inc. raised its stake in Core Laboratories N.V. by 3.5% in the first quarter. Vanguard Group Inc. now owns 3,616,058 shares of the oil and gas company’s stock valued at $417,726,000 after buying an additional 123,416 shares during the last quarter. Sustainable Growth Advisers LP raised its stake in Core Laboratories N.V. by 8.9% in the first quarter. Sustainable Growth Advisers LP now owns 1,713,008 shares of the oil and gas company’s stock valued at $197,886,000 after buying an additional 140,378 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC raised its stake in Core Laboratories N.V. by 2.8% in the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,679,724 shares of the oil and gas company’s stock valued at $194,042,000 after buying an additional 46,010 shares during the last quarter.

Shares of Core Laboratories N.V. (NYSE CLB) traded down 2.02% on Friday, reaching $105.69. 780,049 shares of the company traded hands. The stock has a market cap of $4.67 billion, a price-to-earnings ratio of 69.99 and a beta of 1.60. The stock has a 50 day moving average of $103.54 and a 200 day moving average of $111.27. Core Laboratories N.V. has a 52-week low of $96.30 and a 52-week high of $125.83.

Core Laboratories N.V. (NYSE:CLB) last posted its earnings results on Wednesday, April 19th. The oil and gas company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.03. The company had revenue of $157.81 million during the quarter, compared to analysts’ expectations of $150.44 million. Core Laboratories N.V. had a net margin of 11.10% and a return on equity of 43.28%. Core Laboratories N.V.’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.37 EPS. On average, analysts expect that Core Laboratories N.V. will post $2.18 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, August 14th. Stockholders of record on Monday, July 17th will be paid a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date of this dividend is Thursday, July 13th. Core Laboratories N.V.’s dividend payout ratio is presently 145.70%.

COPYRIGHT VIOLATION WARNING: “[[title]]” was originally published by [[site]] and is the sole property of of [[site]]. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at [[permalink]].

Several equities research analysts recently issued reports on CLB shares. Loop Capital raised shares of Core Laboratories N.V. from a “hold” rating to a “buy” rating and lifted their price objective for the company from $125.00 to $130.00 in a research note on Friday, April 21st. Royal Bank Of Canada set a $145.00 price objective on shares of Core Laboratories N.V. and gave the company a “buy” rating in a research note on Saturday, June 17th. Zacks Investment Research lowered shares of Core Laboratories N.V. from a “buy” rating to a “hold” rating in a research note on Friday, June 23rd. BidaskClub raised shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Tuesday, June 13th. Finally, ABN Amro raised shares of Core Laboratories N.V. to a “hold” rating in a research note on Friday, April 21st. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $122.36.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).